Results 26,901-26,920 of 46,081 for speaker:Simon Harris

Written Answers — Department of Health: Hospital Equipment (24 Apr 2018)

Simon Harris: Against a background of growing demand for unscheduled care and high acute hospital occupancy rates, Government provided €30 million in 2017 and a further €40 million in 2018 for measures to increase acute hospital capacity and alleviate overcrowding in Emergency Departments.  Almost 50% of this funding was used to deliver home support packages and transitional care...

Written Answers — Department of Health: Medicinal Products Reimbursement (24 Apr 2018)

Simon Harris: The HSE has statutory responsibility for medicine pricing and reimbursement decisions, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013.  As Minister for Health, I do not have any statutory power or function in relation to the reimbursement of medicines. The Act specifies the criteria for decisions on the reimbursement of medicines. In line with the...

Written Answers — Department of Health: Hospital Services (24 Apr 2018)

Simon Harris: Following an independent review of the need for a second cath lab in University Hospital Waterford (UHW), the Herity report concluded that the needs of the effective catchment population for Waterford University Hospital could be accommodated within a single cath lab. Funding has been provided to support extension of the existing cath lab operating hours to 12 weekly sessions per week,...

Written Answers — Department of Health: Medical Aids and Appliances Provision (24 Apr 2018)

Simon Harris: As this is a service matter it has been referred to the HSE for direct reply to the Deputy.

Written Answers — Department of Health: Hospitals Data (24 Apr 2018)

Simon Harris: In relation to the particular query raised, as this is a service matter, I have asked the HSE to respond to the Deputy directly.

Written Answers — Department of Health: Medicinal Products Regulation (24 Apr 2018)

Simon Harris: The legal framework for provision of detailed warnings for medicines across the EU is through the product information, which specifically provides for the format and content of these documents. The summary of product characteristics (SmPC) for the healthcare professional and the package leaflet (PL) for patients are reviewed and approved as an intrinsic part of the licensing of a...

Written Answers — Department of Health: Hospital Appointments Administration (24 Apr 2018)

Simon Harris: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. The National...

Written Answers — Department of Health: Consultancy Contracts Expenditure (24 Apr 2018)

Simon Harris: The amount paid to the company referred to in the details supplied was €324,700 (exclusive of VAT) for the provision of technical, analytical, and engagement expertise, along with the design and printing of the 2018 Health Service Capacity Review.

Written Answers — Department of Health: Patient Transport Data (24 Apr 2018)

Simon Harris: As this is a service issue, I have asked the HSE to reply to you directly.

Written Answers — Department of Health: Medicinal Products Licensing (24 Apr 2018)

Simon Harris: Since August 2014 Brentuximab vedotin has been approved and funded by the HSE for use in relapsed or refractory CD30+ Hodgkin Lymphoma following Autologous Stem Cell Transplantation (ASCT) or following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option as well as for use in relapsed or refractory systemic anaplastic large cell lymphoma (sALCL). A...

Written Answers — Department of Health: National Treatment Purchase Fund Data (24 Apr 2018)

Simon Harris: In the first quarter of 2018, the number of persons that have received treatment under the National Treatment Purchase Fund is 3,801. The number of persons treated on the GI Scopes waiting list is 541. 

Written Answers — Department of Health: National Treatment Purchase Fund Data (24 Apr 2018)

Simon Harris: In 2017, the number of persons that received treatment under the National Treatment Purchase Fund was 5,917. The number of persons treated on the GI Scopes waiting list was 700. 

Written Answers — Department of Health: Infectious Diseases (24 Apr 2018)

Simon Harris: Lyme disease (also known as Lyme borreliosis) is an infection caused by a spiral-shaped bacterium called Borrelia burgdorferi.  It is transmitted to humans by bites from ticks infected with the bacteria.  The infection is generally mild affecting only the skin but can occasionally be more severe and highly debilitating.  Lyme disease is diagnosed by medical history and physical...

Written Answers — Department of Health: Health Service Capacity Review (24 Apr 2018)

Simon Harris: Given the timelines in which the Capacity Review had to be conducted in order to inform the new National Development Plan, it was not possible to include a full workforce planning exercise within the scope of the Review. It is important to note that aspects of the primary care workforce were included within the scope of the review, where the key units of capacity were...

Written Answers — Department of Health: Health Services Staff (24 Apr 2018)

Simon Harris: As you may already be aware, I launched the National Strategic Framework for Health and Social Care Workforce Planning in November 2017.  This Framework will support the development and implementation of a more consistent approach to strategic workforce planning.  It will also support the establishment of structures and governance arrangements to enable the application of this...

Written Answers — Department of Health: Health Service Capacity Review (24 Apr 2018)

Simon Harris: In carrying out the Health Service Capacity Review, activity and resource data was drawn from sources such as HIPE (the Hospital InPatient Enquiry system), the HSE, the Critical Care Programme, the Nursing Home Support Scheme, data from a survey of private hospitals and other surveys such as Healthy Ireland, published reports and stakeholder consultation, while waiting list data was drawn...

Written Answers — Department of Health: Health Service Capacity Review (24 Apr 2018)

Simon Harris: The Health Service Capacity Review examined current and projected demand and capacity across not just acute hospitals, but also primary and social care.  In terms of examining acute hospital capacity, the Review looked at bed numbers under four categories – Inpatient, Daycase, Acute Medical Units and Adult Critical Care and it took the year 2016 as its base year.  Future...

Written Answers — Department of Health: Hospital Appointments Status (24 Apr 2018)

Simon Harris: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. The National...

Written Answers — Department of Health: Civil Registration Service (24 Apr 2018)

Simon Harris: The civil registration service is operated by the Health Service Executive on behalf of the General Register Office under the aegis of the Department of Employment Affairs and Social Protection.  I have referred your question to the Health Service Executive to address the specific issue raised and for direct reply to the Deputy.

Written Answers — Department of Health: Civil Defence (24 Apr 2018)

Simon Harris: As this is a service issue, I have asked the HSE to reply to you directly.